TREO Abdominal Stent-Graft System 28-L2-11-140U (UDI 08435761052197)Recalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of TREO Abdominal Stent-Graft System (73)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08435761052197), received between Apr 2, 2025 and Apr 2, 2025 — classified as 1 injury.
The most frequently reported specific device problem is “Device Endoleak” (1 report).
1 other recall cover devices cleared under the same FDA submission (P190015); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Endoleak1
- Device Slipped1
Patient problems
- Clinical Endoleak1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryApr 2, 2025Device Slipped; Device Endoleak; Device Slipped; Device Endoleak
"SUBJECT (B)(6) HAD THEIR 3-YEAR FOLLOW-UP ON (B)(6) 2025 WITHOUT ANY COMPLAINTS. THE CT DATED (B)(6) 2025 NOTED A PERSISTENT SUSPECTED TYPE II ENDOLEAK, CONFIRMED AS SUSPECTED BY THE INVESTIGATOR INITIALLY, PROMPTING AN ANGIO WITH POSSIBLE REINTERVENTION. THE MAX DIAMETER OF LESION WAS CONFIRMED BY THE INVESTIGATOR AS 55MM, WHICH IS THE SAME AS THE PRIOR 2-YEAR FOLLOW-UP AND <5MM INCREASE COMPARED TO 30-DAY FOLLOW-UP. THE INVESTIGATOR ADDITIONALLY NOTED A 10MM MIGRATION OF THE DEVICE, HOWEVER IT WAS STILL DEEMED PATENT. THE SUBJECT WAS ADMITTED ON (B)(6) 2025 AND UNDERWENT ANGIO WITH REINTERVENTION DUE TO WHAT WAS DETERMINED TO BE A NEW TYPE IA ENDOLEAK BY THE INVESTIGATOR. A SMALL ENDOLEAK ON THE RIGHT POSTERIOR ASPECT OF THE GRAFT WAS NOTED PROMPTING PLACEMENT OF A 30MM TERUMO AORTIC CUFF (LOT: 2402010416) PROXIMALLY. THERE WERE NO COMPLICATIONS DURING THE PROCEDURE. THE EVENT WAS ASSESSED AS RELATED TO DEVICE AND INDEX PROCEDURE. THE INVESTIGATOR FURTHER SPECIFIED THERE WAS NOT A DEVICE DEFICIENCY NOR DID THE REINTERVENTION OCCUR DUE TO A DEVICE DEFICIENCY." PATIENT OUTCOME: "THE SUBJECT WAS DISCHARGED ON (B)(6)2025 IN STABLE CONDITION, BUT THE EVENT IS CURRENTLY ONGOING. ADDIT
Patient problems: Clinical Endoleak
MAUDE report 21756272 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P190015. One submission often covers many models, so check the product and lot details in each record.
- Z-1689-2023 · May 3, 2023 · Open, ClassifiedThe TREO ABDOMINAL STENT-GRAFT SYSTEM (TREO) consists of four types of implants, specifically a Main Bifurcated Stent-Graft, a Leg Extension Stent-Graft, a Proximal Cuff Stent-Graf
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page